Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Nguyen, A. Bérézné, T. Baubet, C. Mestre-Stanislas, F. Rannou, A. Papelard, S. Morell-Dubois, M. Revel, L. Guillevin, S. Poiraudeau, L. Mouthon (2011)
Association of Gender with Clinical Expression, Quality of Life, Disability, and Depression and Anxiety in Patients with Systemic SclerosisPLoS ONE, 6
J. Ryan, T. Thenappan, N. Luo, Thanh Ha, Amit Patel, S. Rich, S. Archer (2012)
The WHO classification of pulmonary hypertension: A case-based imaging compendiumPulmonary Circulation, 2
S. Nagueh, C. Appleton, T. Gillebert, P. Marino, J. Oh, O. Smiseth, A. Waggoner, F. Flachskampf, P. Pellikka, Arturo Evangelisa (2008)
Recommendations for the evaluation of left ventricular diastolic function by echocardiography.European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology, 10 2
L. Olivotti, D. Cosmi, A. Nicolino, L. Martinelli, S. Moshiri, G. Danzi (2017)
Large Left Ventricular Aneurysm and Multifocal Myocardial Involvement in a Patient With Systemic Sclerosis.The Canadian journal of cardiology, 33 7
G. Simonneau, M. Gatzoulis, M. Gatzoulis, I. Adatia, I. Adatia, D. Celermajer, D. Celermajer, C. Denton, A. Ghofrani, M. Sánchez, R. Kumar, M. Landzberg, R. Machado, H. Olschewski, I. Robbins, Rogiero Souza (2009)
Updated clinical classification of pulmonary hypertension.Journal of the American College of Cardiology, 62 25 Suppl
P. Lindqvist, K. Caidahl, G. Neuman-Andersen, C. Ozolins, S. Rantapää-Dahlqvist, A. Waldenström, Elsadig Kazzam (2005)
Disturbed right ventricular diastolic function in patients with systemic sclerosis: a Doppler tissue imaging study.Chest, 128 2
A. Kahan, Y. Allanore (2006)
Primary myocardial involvement in systemic sclerosis.Rheumatology, 45 Suppl 4
F. Fernandes, F. Ramires, E. Arteaga, B. Ianni, E. Bonfá, C. Mady (2003)
Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study.Journal of cardiac failure, 9 4
W. D'Angelo, J. Fries, A. Masi, L. Shulman (1969)
Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.The American journal of medicine, 46 3
C. Meune, J. Avouac, K. Wahbi, L. Cabanes, J. Wipff, L. Mouthon, L. Guillevin, A. Kahan, Y. Allanore (2008)
Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients.Arthritis and rheumatism, 58 6
M. Turiel, L. Gianturco, C. Ricci, P. Sarzi-Puttini, L. Tomasoni, V. Colonna, P. Ferrario, O. Epis, F. Atzeni (2013)
Silent cardiovascular involvement in patients with diffuse systemic sclerosis: a controlled cross‐sectional studyArthritis Care & Research, 65
K. Yiu, A. Schouffoer, N. Marsan, M. Ninaber, J. Stolk, T. Vlieland, R. Scherptong, V. Delgado, E. Holman, H. Tse, T. Huizinga, Jeroen Bax, A. Schuerwegh (2011)
Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias.Arthritis and rheumatism, 63 12
G. Armstrong, G. Whalley, R. Doughty, Greg Gamble, S. Flett, P. Tan, D. Sharpe (1996)
Left ventricular function in scleroderma.British journal of rheumatology, 35 10
J. Candell‐Riera, L. Armadans-Gil, C. Simeón, J. Castell‐Conesa, V. Fonollosa-Plá, H. García-del-Castillo, J. Vaqué-Rafart, M. Vilardell, J. Soler‐Soler (1996)
Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis.Arthritis and rheumatism, 39 7
P. Groote, V. Gressin, E. Hachulla, P. Carpentier, L. Guillevin, A. Kahan, J. Cabane, C. Francès, N. Lamblin, E. Diot, F. Patat, J. Sibilia, H. Petit, J. Cracowski, P. Clerson, M. Humbert (2007)
Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosisAnnals of the Rheumatic Diseases, 67
(2013)
Systemic sclerosis-associated pulmonary arterial hypertension.
C. Meune, O. Vignaux, A. Kahan, Y. Allanore (2010)
Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies.Archives of cardiovascular diseases, 103 1
C. Ferri, D. Giuggioli, M. Sebastiani, M. Colaci, M. Emdin (2005)
Heart involvement and systemic sclerosisLupus, 14
W. Gaasch, M. Zile (2004)
Left ventricular diastolic dysfunction and diastolic heart failure.Annual review of medicine, 55
E. Durmuş, M. Sunbul, K. Tigen, T. Kıvrak, Gulsen Ozen, Ibrahim Sari, H. Direskeneli, Y. Basaran (2015)
Right ventricular and atrial functions in systemic sclerosis patients without pulmonary hypertensionHerz, 40
AbstractBackground: The impact of pulmonary arterial hypertension (PAH) on left ventricular performance in patients with scleroderma is still unknown. This study aims to perform a comparative echocardiographic analysis of left ventricular function between two different etiological varieties of PAH, namely PAH caused by systemic sclerosis as a representative of systemic inflammatory diseases and PAH caused by myocardial ischemia.Material and method: We conducted a prospective observational study on 82 patients, of which 36 were with documented PAH, with the systolic pressure in the pulmonary artery above 35 mmHg, and 46 were patients with normal pulmonary artery pressure. The study population was divided into two groups, based on the etiology of PAH: group 1 included patients diagnosed with scleroderma (n = 48); group 2 included patients with coronary artery disease (n = 35). Patients from each group were divided into two subgroups based on the diagnosis of PAH: subgroup 1A – subjects with scleroderma and associated PAH (n = 20); subgroup 1B – subjects with scleroderma without PAH (n = 28); subgroup 2A – ischemic patients with associated PAH (n = 16); and subgroup 2B – patients with ischemic disease without PAH (n = 19).Results: A significant difference between LVEF values in patients with PAH versus those without PAH in the ischemic group (p = 0.023) was recorded. Compared to scleroderma subjects, ischemic patients presented significantly lower values of LVEF in both PAH and non-PAH subgroups (p <0.0001 and p <0.0001, respectively). Linear regression analysis between sPAP and LVEF revealed a significant negative correlation only for the ischemia group (r = −0.52, p = 0.001) and the scleroderma 2B subgroup (r = −0.51, p = 0.04). Tissue Doppler analysis of left ventricular function revealed a significant impact of PAH on left ventricular diastolic performance in the ischemic group.Conclusions: Compared to patients with coronary artery disease, those with scleroderma present a less pronounced deterioration of LVEF in response to pulmonary arterial hypertension.
Journal of Interdisciplinary Medicine – de Gruyter
Published: Sep 1, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.